Laser interstitial thermal therapy followed by minimal-access transsulcal resection for the treatment of large and difficult to access brain tumors
- PMID: 27690658
- DOI: 10.3171/2016.8.FOCUS16233
Laser interstitial thermal therapy followed by minimal-access transsulcal resection for the treatment of large and difficult to access brain tumors
Abstract
OBJECTIVE Laser interstitial thermal therapy (LITT), sometimes referred to as "stereotactic laser ablation," has demonstrated utility in a subset of high-risk surgical patients with difficult to access (DTA) intracranial neoplasms. However, the treatment of tumors larger than 10 cm3 is associated with suboptimal outcomes and morbidity. This may limit the utility of LITT in dealing with precisely those large or deep tumors that are most difficult to treat with conventional approaches. Recently, several groups have reported on minimally invasive transsulcal approaches utilizing tubular retracting systems. However, these approaches have been primarily used for intraventricular or paraventricular lesions, and subtotal resections have been reported for intraparenchymal lesions. Here, the authors describe a combined approach of LITT followed by minimally invasive transsulcal resection for large and DTA tumors. METHODS The authors retrospectively reviewed the results of LITT immediately followed by minimally invasive, transsulcal, transportal resection in 10 consecutive patients with unilateral, DTA malignant tumors > 10 cm3. The patients, 5 males and 5 females, had a median age of 65 years. Eight patients had glioblastoma multiforme (GBM), 1 had a previously treated GBM with radiation necrosis, and 1 had a melanoma brain metastasis. The median tumor volume treated was 38.0 cm3. RESULTS The median tumor volume treated to the yellow thermal dose threshold (TDT) line was 83% (range 76%-92%), the median tumor volume treated to the blue TDT line was 73% (range 60%-87%), and the median extent of resection was 93% (range 84%-100%). Two patients suffered mild postoperative neurological deficits, one transiently. Four patients have died since this analysis and 6 remain alive. Median progression-free survival was 280 days, and median overall survival was 482 days. CONCLUSIONS Laser interstitial thermal therapy followed by minimally invasive transsulcal resection, reported here for the first time, is a novel option for patients with large, DTA, malignant brain neoplasms. There were no unexpected neurological complications in this series, and operative characteristics improved as surgeon experience increased. Further studies are needed to elucidate any differences in survival or quality of life metrics.
Keywords: CUSA = cavitron ultrasonic surgical aspirator; DTA = difficult to access; GBM = glioblastoma multiforme; LITT; LITT = laser interstitial thermal therapy; NeuroBlate; OS = overall survival; PFS = progression-free survival; TDT = thermal dose threshold; WBRT = whole-brain radiation therapy; craniotomy; glioma; iMRI = intraoperative MRI; metastatic; stereotactic laser ablation; tumor.
Similar articles
-
Intracerebral laser interstitial thermal therapy followed by tumor resection to minimize cerebral edema.Neurosurg Focus. 2016 Oct;41(4):E13. doi: 10.3171/2016.7.FOCUS16224. Neurosurg Focus. 2016. PMID: 27690659
-
Laser interstitial thermal therapy for newly diagnosed and recurrent glioblastoma.Neurosurg Focus. 2016 Oct;41(4):E12. doi: 10.3171/2016.7.FOCUS16234. Neurosurg Focus. 2016. PMID: 27690657
-
Renaissance of laser interstitial thermal ablation.Neurosurg Focus. 2015 Mar;38(3):E13. doi: 10.3171/2014.12.FOCUS14762. Neurosurg Focus. 2015. PMID: 25727222 Review.
-
MRI-Guided Interstitial Laser Ablation for Intracranial Lesions: A Large Single-Institution Experience of 133 Cases.Stereotact Funct Neurosurg. 2017;95(6):417-428. doi: 10.1159/000485387. Epub 2018 Jan 17. Stereotact Funct Neurosurg. 2017. PMID: 29339639
-
Stereotactic Laser Ablation of Glioblastoma.Neurosurg Clin N Am. 2021 Jan;32(1):105-115. doi: 10.1016/j.nec.2020.08.006. Epub 2020 Nov 5. Neurosurg Clin N Am. 2021. PMID: 33223019 Review.
Cited by
-
Meta-analysis of the impact of laser interstitial hyperthermia on wound healing complications in brain tumors.Int Wound J. 2024 Jan;21(1):e14628. doi: 10.1111/iwj.14628. Int Wound J. 2024. Retraction in: Int Wound J. 2025 Apr;22(4):e70488. doi: 10.1111/iwj.70488. PMID: 38272817 Free PMC article. Retracted.
-
Medical Device Advances in the Treatment of Glioblastoma.Cancers (Basel). 2022 Oct 29;14(21):5341. doi: 10.3390/cancers14215341. Cancers (Basel). 2022. PMID: 36358762 Free PMC article. Review.
-
Management of Intracranial Metastatic Disease With Laser Interstitial Thermal Therapy.Front Oncol. 2018 Oct 31;8:499. doi: 10.3389/fonc.2018.00499. eCollection 2018. Front Oncol. 2018. PMID: 30430083 Free PMC article.
-
Contemporary Surgical Management of Deep-Seated Metastatic Brain Tumors Using Minimally Invasive Approaches.Front Oncol. 2018 Nov 28;8:558. doi: 10.3389/fonc.2018.00558. eCollection 2018. Front Oncol. 2018. PMID: 30547010 Free PMC article. Review.
-
Role of Laser Interstitial Thermal Therapy in the Management of Primary and Metastatic Brain Tumors.Curr Treat Options Oncol. 2021 Oct 23;22(12):108. doi: 10.1007/s11864-021-00912-6. Curr Treat Options Oncol. 2021. PMID: 34687357 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical